Gefitinib in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

October 31, 2005

Conditions
Sarcoma
Interventions
DRUG

gefitinib

Trial Locations (16)

1200

Cliniques Universitaires Saint-Luc, Brussels

13385

CHU de la Timone, Marseille

33076

Institut Bergonie, Bordeaux

69373

Centre Leon Berard, Lyon

75248

Institut Curie - Section Medicale, Paris

B-3000

U.Z. Gasthuisberg, Leuven

06189

Centre Antoine Lacassagne, Nice

F-94805

Institut Gustave Roussy, Villejuif

1066 CX

Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam

2300 RC

Leiden University Medical Center, Leiden

NL-6500 HB

Nijmegen Cancer Center at Radboud University Medical Center, Nijmegen

3008 AE

Daniel Den Hoed Cancer Center at Erasmus Medical Center, Rotterdam

LS9 7TF

Leeds Cancer Centre at St. James's University Hospital, Leeds

SW3 6JJ

Royal Marsden NHS Foundation Trust - London, London

WIT 3AA

Meyerstein Institute of Oncology at University College of London Hospitals, London

M20 4BX

Christie Hospital N.H.S. Trust, Manchester

All Listed Sponsors
lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00052754 - Gefitinib in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma | Biotech Hunter | Biotech Hunter